Literature DB >> 6692569

Alkaline haematin D-575, a new tool for the determination of haemoglobin as an alternative to the cyanhaemiglobin method. II. Standardisation of the method using pure chlorohaemin.

H U Wolf, W Lang, R Zander.   

Abstract

Chlorohaemin with high purity (greater than 99%), a stable and well-defined compound, can be used as a primary standard for the standardisation of a haemoglobin assay based on alkaline haematin D-575 [6]. Dissolved in a solution of 25 g Triton X-100 per litre of 0.1 mol/l NaOH ('AHD solution'), the millimolar absorbance coefficient of the end product (alkaline haematin D-575) is 6.960 +/- 0.046 [l X mmol-1 X cm-1] at 575 nm. Within the range of haemoglobin concentrations of 5 to 25 g/100 ml there is a strong linear relation between chlorohaemin concentration and absorbance with a deviation of less than or equal to 2% from the theoretical values. As compared to the conventional cyanhaemiglobin standard solutions, standardisation with pure chlorohaemin is the method of choice because of the simplicity of the preparation of standard solutions, which can be done in every laboratory, and the stability of both the solid compound chlorohaemin and its solutions in alkaline Triton X-100. For the first time a real standard for quality control in haemoglobinometry is recommended: a concentrated solution which behaves like blood, i.e. the simulation of all steps in haemoglobin determination (dilution and photometry) is possible.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692569     DOI: 10.1016/0009-8981(84)90251-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Childhood socioeconomic disadvantage and prediabetes and diabetes in later life: a study of biopsychosocial pathways.

Authors:  Vera Tsenkova; Tetyana Pudrovska; Arun Karlamangla
Journal:  Psychosom Med       Date:  2014-10       Impact factor: 4.312

2.  Perceived weight discrimination amplifies the link between central adiposity and nondiabetic glycemic control (HbA1c).

Authors:  Vera K Tsenkova; Deborah Carr; Dale A Schoeller; Carol D Ryff
Journal:  Ann Behav Med       Date:  2011-04

3.  Stress eating and health. Findings from MIDUS, a national study of US adults.

Authors:  Vera Tsenkova; Jenifer Morozink Boylan; Carol Ryff
Journal:  Appetite       Date:  2013-06-06       Impact factor: 3.868

4.  Childhood Socioeconomic Disadvantage, Occupational, Leisure-Time, and Household Physical Activity, and Diabetes in Adulthood.

Authors:  Vera K Tsenkova; Chioun Lee; Jennifer Morozink Boylan
Journal:  J Phys Act Health       Date:  2017-09-13

5.  Anger, adiposity, and glucose control in nondiabetic adults: findings from MIDUS II.

Authors:  Vera K Tsenkova; Deborah Carr; Christopher L Coe; Carol D Ryff
Journal:  J Behav Med       Date:  2012-10-12

6.  Parental History of Diabetes, Positive Affect, and Diabetes Risk in Adults: Findings from MIDUS.

Authors:  Vera K Tsenkova; Arun S Karlamangla; Carol D Ryff
Journal:  Ann Behav Med       Date:  2016-12

7.  Evaluation of the alkaline haematin D-575 method for haemoglobin estimation in east Africa.

Authors:  O E Lema; J Y Carter; P A Arube; C G Munafu; M W Wangai; P H Rees
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

8.  Leisure-time, occupational, household physical activity and insulin resistance (HOMAIR) in the Midlife in the United States (MIDUS) national study of adults.

Authors:  Vera K Tsenkova
Journal:  Prev Med Rep       Date:  2017-01-03

9.  α-Synuclein in blood cells differentiates Parkinson's disease from healthy controls.

Authors:  Suaad Abd Elhadi; Jessica Grigoletto; Maura Poli; Paolo Arosio; David Arkadir; Ronit Sharon
Journal:  Ann Clin Transl Neurol       Date:  2019-11-19       Impact factor: 4.511

10.  Function of Hemoglobin-Based Oxygen Carriers: Determination of Methemoglobin Content by Spectral Extinction Measurements.

Authors:  Kathrin Smuda; Jonas Gienger; Philipp Hönicke; Jörg Neukammer
Journal:  Int J Mol Sci       Date:  2021-02-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.